Latest News about JNJ
Recent news which mentions JNJ
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
From Benzinga
Could This Issue Sink Johnson & Johnson's Stock Price?
September 11, 2023
Tickers
JNJ
From Motley Fool
3 Bulletproof Stocks to Buy Before the Next Recession Strikes
September 11, 2023
From InvestorPlace
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.
September 11, 2023
From Motley Fool
The 7 Best Warren Buffett Stocks to Buy Now: September 2023
September 10, 2023
From InvestorPlace
New to Investing? Here's How You Can Get Started With $500.
September 10, 2023
From Motley Fool
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
September 09, 2023
From Motley Fool
The 5 Best Healthcare Stocks to Buy Now: September 2023
September 08, 2023
From InvestorPlace
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
September 08, 2023
From InvestorPlace
3 Shaky Stocks to Sell in September Before It’s Too Late
September 08, 2023
From InvestorPlace
The 7 Best Dow Stocks to Buy Now: September 2023
September 08, 2023
Tags
MSFT
JNJ
NASDAQ:AAPL,NYSE:KO,NYSE:JNJ,NYSE:MCD,NASDAQ:MSFT,NYSE:NKE,NYSE:V,NYSE:KVUE,NASDAQ:NVDA,NASDAQ:ATVI
From InvestorPlace
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
September 07, 2023
From Motley Fool
From InvestorPlace
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population
September 06, 2023
From Benzinga
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?
September 06, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
From Benzinga
7 Retirement Stocks That Every Long-Term Investor Should Own Now
September 06, 2023
From InvestorPlace
Is J&J a Buy After the Kenvue Separation?
September 06, 2023
From Motley Fool
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
From Benzinga
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation
September 05, 2023
From Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
From Benzinga
3 Dow Stocks to Sell in September Before They Crash and Burn
September 04, 2023
From InvestorPlace
4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032
September 03, 2023
From Motley Fool
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
September 02, 2023
From Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
From Benzinga
7 Cash Cow Stocks for Recession-Resilient Dividends
September 01, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.